Background Image
Table of Contents Table of Contents
Previous Page  35 / 84 Next Page
Information
Show Menu
Previous Page 35 / 84 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 2, March/April 2018

AFRICA

97

7.

Leach NV, Dronca E, Vesa SC, Sampelean DP, Craciun EC, Lupsor M

,

et al.

Serum homocysteine levels, oxidative stress and cardiovascular risk

in non-alcoholic steatohepatitis.

Eur J Intern Med

2014;

25

(8): 762–767.

8.

Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER

,

et al.

Use of carotid ultrasound to identify subclinical vascular disease

and evaluate cardiovascular disease risk: a consensus statement from

the American Society of Echocardiography Carotid Intima-Media

Thickness Task Force. Endorsed by the Society for Vascular Medicine.

J

Am Soc Echocardiogr

2008;

21

(2): 93–111.

9.

Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui

MH

, et al.

Prevention Conference V: Beyond secondary prevention:

identifying the high-risk patient for primary prevention: noninvasive

tests of atherosclerotic burden: Writing Group III.

Circulation

2000;

101

(1): E16–22.

10. Berman DS, Arnson Y, Rozanski A. Coronary artery calcium scanning:

the agatston score and beyond.

JACC Cardiovasc Imaging

2016;

9

(12):

1417–1419.

11. Tota-Maharaj R, Joshi PH, Budoff MJ, Whelton S, Zeb I, Rumberger

J

, et al.

Usefulness of regional distribution of coronary artery calcium

to improve the prediction of all-cause mortality.

Am J Cardiol

2015;

115

(9): 1229–1234.

12. Tota-Maharaj R, Al-Mallah MH, Nasir K, Qureshi WT, Blumenthal

RS, Blaha MJ. Improving the relationship between coronary artery

calcium score and coronary plaque burden: addition of regional meas-

ures of coronary artery calcium distribution.

Atherosclerosis

2015;

238

(1): 126–131.

13. Park HE, Kwak MS, Kim D, KimMK, Cha MJ, Choi SY. Nonalcoholic

fatty liver disease is associated with coronary artery calcification devel-

opment: a longitudinal study.

J Clin Endocrinol Metab

2016;

101

(8):

3134–3143.

14. Kim J, Lee DY, Park SE, Park CY, Lee WY, Oh KW

, et al.

Increased

risk for development of coronary artery calcification in subjects with

non-alcoholic fatty liver disease and systemic inflammation.

PLoS One

2017;

12

(7): e0180118.

15. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK.

NAFLD as a risk factor for the development of diabetes and the meta-

bolic syndrome: an eleven-year follow-up study.

Am J Gastroenterol

2009;

104

(4): 861–867.

16. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T

,

et al.

Carotid intima–media thickness and presence or absence of

plaque improves prediction of coronary heart disease risk: the ARIC

(Atherosclerosis Risk In Communities) study.

J Am Coll Cardiol

2010;

55

(15): 1600–1607.

17. Myers RP. Noninvasive diagnosis of nonalcoholic fatty liver disease.

Ann Hepatol

2009;

8

(Suppl 1): S25–33.

18. Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histo-

gram technique that compares liver and renal cortical echo amplitudes.

J Clin Ultrasound

1996;

24

(1): 25–29.

19. Mohammadi A, Bazazi A, Ghasemi-Rad M. Evaluation of atheroscle-

rotic findings in patients with nonalcoholic fatty liver disease.

Int J Gen

Med

2011;

4

: 717–722.

20. Cuenza LR, Razon TLJ, Dayrit JC. Correlation between severity of

ultrasonographic nonalcoholic fatty liver disease and cardiometabolic

risk among Filipino wellness patients.

J Cardiovasc Thorac Res

2017;

9

(2): 85–89.

21. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr.,

Detrano R. Quantification of coronary artery calcium using ultrafast

computed tomography.

J Am Coll Cardiol

1990;

15

(4): 827–832.

22. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary

calcification, coronary disease risk factors, C-reactive protein, and

atherosclerotic cardiovascular disease events: the St. Francis Heart

study.

J Am Coll Cardiol

2005;

46

(1): 158–165.

23. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna

RC

, et al.

Carotid atherosclerosis and coronary heart disease in the

metabolic syndrome: prospective data from the Bruneck study.

Diabetes

Care

2003;

26

(4): 1251–1257.

24. Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM

, et al.

Suspected nonalcoholic fatty liver disease and mortality risk in a popu-

lation-based cohort study.

Am J Gastroenterol

2008;

103

(9): 2263–2271.

25. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC,

McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical

and pathological severity.

Gastroenterology

1999;

116

(6): 1413–1419.

26. Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A

, et al.

A systematic review: burden and severity of subclinical cardiovascular

disease among those with nonalcoholic fatty liver; should we care?

Atherosclerosis

2013;

230

(2): 258–267.

27. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson

SK, Jr. Carotid-artery intima and media thickness as a risk factor for

myocardial infarction and stroke in older adults. Cardiovascular Health

Study Collaborative Research Group.

N Engl J Med

1999;

340

(1): 14–22.

28. Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K.

Interrelationship between non-invasive measurements of atheroscle-

rosis: flow-mediated dilation of brachial artery, carotid intima-media

thickness and pulse wave velocity.

Atherosclerosis

2004;

173

(1): 13–18.

29. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V

,

et al.

Relationships among regional arterial inflammation, calcifica-

tion, risk factors, and biomarkers: a prospective fluorodeoxyglucose

positron-emission tomography/computed tomography imaging study.

Circ Cardiovasc Imaging

2009;

2

(2): 107–115.

30. Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E

,

et al.

Carotid plaque burden as a measure of subclinical atherosclerosis:

comparison with other tests for subclinical arterial disease in the High

Risk Plaque BioImage study.

J Am Col Cardiol Cardiovasc Imaging

2012;

5

(7): 681–689.

31. Cohen GI, Aboufakher R, Bess R, Frank J, Othman M, Doan D

, et

al.

Relationship between carotid disease on ultrasound and coronary

disease on CT angiography.

J Am CC Cardiovasc Imaging

2013;

6

(11):

1160–1167.

32. Gardin JM, Bartz TM, Polak JF, O’Leary DH, Wong ND. What do

carotid intima–media thickness and plaque add to the prediction of

stroke and cardiovascular disease risk in older adults? The cardiovascu-

lar health study.

J Am Soc Echocardiogr

2014;

27

(9): 998–1005.

33. Gepner AD, Young R, Delaney JA, Tattersall MC, Blaha MJ, Post WS

,

et al.

Comparison of coronary artery calcium presence, carotid plaque

presence, and carotid intima-media thickness for cardiovascular disease

prediction in the Multi-Ethnic Study of Atherosclerosis.

Circ Cardiovasc

Imaging

2015;

8

(1).

34. Folsom AR, Kronmal RA, Detrano RC, O’Leary DH, Bild DE,

Bluemke DA

, et al.

Coronary artery calcification compared with carotid

intima-media thickness in the prediction of cardiovascular disease inci-

dence: the Multi-Ethnic Study of Atherosclerosis (MESA).

Arch Intern

Med

2008;

168

(12): 1333–1339.